11915 LA GRANGE AVE LOS ANGELES, CA 90025 Get Directions
11915 LA GRANGE AVE LOS ANGELES, CA 90025 Get Directions
California Cryobank is a Life Sciences company, with the leading reproductive tissue bank (frozen donor sperm and oocytes), with a strong position in the expanding stem cell services market. As a pioneer in the reproductive tissue banking sector with over 40 years of experience, CCB has developed an unmatched reputation for clinical excellence and superior client service that has allowed it to create longstanding physician relationships and engender trust from clients. Today, the Company enjoys over 50% market share in the donor sperm market, nearly twice the size of its nearest competitor, providing donor sperm to all 50 states and 40 countries. The Company also leads the highly complementary and rapidly growing frozen donor egg market with over 35% market share. CCB’s Stem Cell division (FamilyCord) has more than tripled its revenue since 2008 and benefits from excellent recurring revenue characteristics.
The Company offers an unrivaled range of services across its three complementary businesses that provide strategic marketing benefits and allow CCB to leverage common corporate infrastructure to create a competitive advantage in the market. CCB’s scale, reputation for excellence, and difficult to replicate physician referral relationships uniquely position it for continued rapid growth in both the $300 million reproductive tissue and burgeoning $1.1 billion private stem cell industries in the US. Donor sperm, donor egg and stem cell services benefit from trends driving healthcare and IVF spending. As these services are not covered by insurance, CCB has no third-party or other reimbursement exposure.
· Industry Leading Platform for Scale
- Pioneer in reproductive tissue banking with more than 40 years of institutional knowledge, proprietary technology, and clinical expertise
- Industry leader in the reproductive tissue market, providing significant competitive advantages in a fragmented industry
- Significant international reach with Reproductive shipments to 40 countries and Stem Cell division processing units from 15 countries
Unique Set of Complementary Services
- Unrivaled breadth of services across Reproductive (frozen donor sperm and oocytes) and Stem Cell divisions
- The Reproductive division acts as a natural lead generation source for the Stem Cell division thereby lowering the overall client acquisition cost
- CCB achieves economies of scale and associated cost savings by leveraging key functional areas across multiple businesses
Highly Valued Services that Fundamentally Improve the Quality of Life for its Clients
- Services enhance the lives of its clients by enabling them to fulfill their dreams of having children and protecting their families with stem cell therapies
- Because of the importance of the Company's services, clients and referring physicians focus on quality, service, and selection rather than cost
- Demand for IVF services has remained strong throughout economic cycles, and maintained growth during 2008 and 2011 economic downturns
Highly Talented and Experienced Management Team
- Talented and experienced senior management team with a combination of industry experience, medical and functional expertise, and strategic vision
- Proven track record of driving organic growth and acquisitions (10 acquisitions since 2008) establishing CCB as a platform of choice in the industry
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.